InSCREENeX GmbH

General information

InSCREENeX GmbH
Inhoffenstraße 7
38124 Braunschweig, Lower Saxony
Germany

Contact person: Roland Schucht, Managing Director
Company main phone: +49 (531) 61815080
Company main fax: +49 (531) 61815002
Website: https://inscreenex.de

Year founded:	2009
Source of foundation:	Spin-off from public institution / NPO
Name of foundation source:	Helmholtz-Centre for Infection Research (HZI)

Corporate description / mission:
InSCREENeX GmbH develops and commercializes cellular screening technologies that support the process of biopharmaceutical drug discovery and validation. The company has established two complementary technology platforms : SCREENflex™ and CI-SCREEN™. InSCREENeX offers mammalian cell systems as decision tools for drug development processes.

State of ownership: Private / independent
Headquarters: HQ: Yes

Categorization

Sector:

Biotechnology - R&D Services

Subsector:

Cell culture
Screening
Synthesis services

Business model:

Manufacturer
R&D
Service company

Customer segments:

Large biotech & big pharma
Small biotech

Summary Products / Services / Technologies

Description of products:
Airway Epithelial Cells (hu)
Chondrocytes (hu)
Fibroblasts (hu)
Lymphatic Endothelial Cells (hu)
Macrophages (hu)
Microvasc. Endothel (hu)
Osteoblasts (hu) , etc.

Technology used:
SCREENflex technology
CI-SCREEN technology

Collaborations & Clients

Partnering strategy / collaborations:
ECACC
ascenion
tytonis b.v., etc.